Date Added: 20/01/2017
Date Updated: 20/01/2017
Emerging technologies for the diagnosis, treatment and management of epilepsy
Specialties: Neurology & neurosurgery
Technology Type: Other
Stage of development: Other
Stage of EAA: Assessment Complete
Epilepsy is a common neurological condition that affects around 600,000 people in the UK (equivalent to almost 1 in 100 people). It causes sudden and unprovoked seizures (fits) that start in the brain. There are over 40 different types of epilepsy, and although the condition can start at any age, it is most commonly diagnosed in people under the age of 20 years.
This NIHR HSRIC Horizon Scanning report presents 114 emerging technologies that were identified as being in early clinical stage research for epilepsy: 27 were anti-epileptic drugs and 87 were medical devices, procedures and techniques. These technologies are being developed for use right across the care pathway for epilepsy: 23 (20%) were tests for diagnosing epilepsy and 91 of the technologies (80%) were for the treatment and management of the condition.
Exciting advances are being made across a number of technological areas. For example, anti-epileptic drugs are being developed that can be taken in the form of an oil that can be taken my mouth or a gel that a caregiver can quickly rub onto the skin while a seizure is happening. So-called personalised ‘designer drugs’ are being developed that are tailored to an individual and work exclusively at their focal point of seizure onset.
Epilepsy, Epilepsies, Epileptic, Status epilepticus, SUDEP, Sudden Unexpected Death in Epilepsy, Epileptogenic zone, EZ, Seizure, Sx, Brain, Absence seizure, Petit mal, Fit, Convulsion, Onset zone, Electroclinical syndrome, Neuroimaging, Neurological, Neurosurgery, Neurosurgical